Modifications of Heart Murmurs and Cardiac Output During Fever

NCT ID: NCT04306991

Last Updated: 2020-03-13

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 40 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2020-03-31
• Study Completion Date: 2021-03-31

Brief Summary

The combination of fever and auscultation of a heart murmur suggests the diagnosis of endocarditis. However, fever itself increases cardiac output and could therefore modify heart sounds. The aim of the FeMur study is to measure the modification of heart sounds during fever.

Heart sounds of 15 hospitalized febrile patients with a heart murmur will be recorded using an electronic stethoscope before and after resolution of fever. The records will be analyzed using a computerized application in order to quantify the intensity of heart murmurs.

Detailed Description

Fever is an frequently observed during acute illnesses, particularly infectious diseases. The hemodynamic consequences of fever have been extensively studied. Fever leads to an acceleration of heart rate (approximately 8.5 bpm per degree celsius) and to a moderate drop in blood pressure. Cardiac output increases in the context of heat stress as a result of complex physiological adaptations, including heart rate and systolic function increase while preload and after load decrease.

However, there are no studies on the specific consequences of fever on heart sounds. The question is important since auscultation of a heart murmur in a febrile patient suggests the diagnosis of endocarditis. In endocarditis, the heart murmur, which is present in 85% of cases, is due to the mutilation of heart valves, which requires urgent diagnostic and therapeutic management. Suspicion of endocarditis requires emergency cardiac ultrasonography. However, the proportion of patients with actual endocarditis among patients with heart murmur and fever is low. This could arise from the fact that fever itself may increase or trigger a heart murmur. Indeed, any increase in cardiac output may generate audible turbulence when blood is pumped across a heart valve.

Functional or inorganic murmurs are murmurs triggered by changes in cardiac output or blood viscosity, as opposed to organic murmurs reflecting an anatomical abnormality in the heart. Certain characteristics of the murmur and the context of occurrence can guide the clinical toward one of these two situations, but distinguishing functional from organic murmurs is most often difficult.

The impact of fever on cardiac murmurs has not been experimentally demonstrated. This is the aim of the FeMur study.

For this purpose, heart sounds of 15 patients will be recorded during a febrile ilness and after resolution of fever using an electronic stethoscope and analyzed using a computer application. The average intensity of heart murmurs will be compared between the two periods in order to determine the impact of fever.

Conditions

Heart Murmurs; Fever

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: SEQUENTIAL
• Primary Study Purpose: DIAGNOSTIC
• Blinding Strategy: NONE

Study Groups

Fever

Auscultation using an electronic stethoscope Measurement of cardiac output using echocardiography

Group Type: EXPERIMENTAL

Auscultation using an electronic stethoscope (EKO CORE 4)

Intervention Type: DEVICE

• Auscultation using an electronic stethoscope (EKO CORE 4). Record of at least 3 cardiac cycles.
• Measurement of cardiac output using echocardiography.

Apyrexia

Auscultation using an electronic stethoscope Measurement of cardiac output using echocardiography

Group Type: EXPERIMENTAL

Auscultation using an electronic stethoscope (EKO CORE 4)

Intervention Type: DEVICE

• Auscultation using an electronic stethoscope (EKO CORE 4). Record of at least 3 cardiac cycles.
• Measurement of cardiac output using echocardiography.

Interventions

Auscultation using an electronic stethoscope (EKO CORE 4)

• Auscultation using an electronic stethoscope (EKO CORE 4). Record of at least 3 cardiac cycles.
• Measurement of cardiac output using echocardiography.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Hospitalized febrile patients (body temperature > 38.5°C)
• Aged 18 or older
• Agreement to participate to the study

Exclusion Criteria

• Patients treated with beta-blockers, verapamil, or diltiazem
• Patients with atrial fibrillation
• Pregnancy or breastfeeding
• Patients with severe psychiatric disorder
• Patients with diminished heart sounds

• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University Hospital, Angers

OTHER_GOV

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Vincent Dubee, MD, PhD

Role: STUDY_DIRECTOR

University Hospital, Angers

Central Contacts

Vincent Dubee, MD, PhD

Role: CONTACT

vincent.dubee@chu-angers.fr

0033665807022

Other Identifiers

49RC19_0202

Identifier Type: -

Identifier Source: org_study_id